StonvexLoading…
StonvexStonvexStonvexCore line items from BLND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $30.84M | $123.58M | $91.17M | $58.47M |
Operating Income | $-5.06M | $-21.73M | $-18.15M | $-12.81M |
Net Income | $-8.05M | $-6.80M | $-4.27M | $-16.36M |
EPS (Diluted) | $-0.05 | $-0.10 | $0.02 | $-0.07 |
Total Assets | $161.26M | $170.04M | $188.61M | $182.19M |
Total Liabilities | $52.95M | $41.02M | $47.22M | $55.01M |
Cash & Equivalents | $37.43M | $45.06M | $55.02M | $36.50M |
Free Cash Flow OCF − CapEx | $6.24M | $-81.00K | $-60.00K | $5.70M |
Shares Outstanding | 247.34M | 256.04M | 260.10M | 260.05M |